PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

810, 2015

Valeria Barresi et al., KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases. Pathology

1509, 2015

Matteo Landriscina et al., RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study. Oncology Letters

1509, 2015

Valentina Guarneri et al., Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer. The Oncologist

1509, 2015

Maria Orsaria et al., HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping? Anticancer Research

808, 2015

Riccardo Giannini et al., Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules. Cancer Cytopathology

108, 2015

Giulio Cabrini et al., Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Journal of Oncology

108, 2015

Cangi MG, Biavasco R, Cavalli G, et al BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease Annals of the Rheumatic Diseases 2015;74:1596-1602.

108, 2015

Andrea Imperatori et al., Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: case report with genetic and epigenetic analyses. BMC Cancer

2807, 2015

Veronica Villani, Beatrice Casini, Andrea Pace, et al., “The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma,” Disease Markers, vol. 2015, Article ID 604719, 6 pages, 2015. doi:10.1155/2015/604719

307, 2015

Maria Teresa Voso et al., Fanconi anemia gene variants in therapy-related myeloid neoplasms. Blood Cancer Journal

906, 2015

Marta Schirippa et al., BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection. British Journal of Cancer

806, 2015

Hauck, F., Oliveira-Silva, M., Dreyer, J.H. et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch (2015) 466: 685.

Previous 303132 Next